Guideline for Evaluating Peripheral Retinal Neovascularization with Macular Dragging

Primary Differential Diagnoses

Neovascularization in PDR originates at the border between perfused and non‑perfused retinal tissue, reflecting an angiogenic response to extensive retinal ischemia caused by capillary closure. 1
High‑risk PDR is defined by the presence of neovascularization accompanied by vitreous or preretinal hemorrhage, or by moderate‑to‑severe neovascular complexes at predetermined retinal locations. 3
When assessing for PDR, clinicians should specifically look for a history of diabetes, intraretinal microaneurysms, hemorrhages, venous beading, cotton‑wool spots, and determine whether neovascularization involves the optic disc (NVD) or elsewhere (NVE). 4

FEVR is a hereditary disorder that produces peripheral retinal avascular zones, leading to neovascularization and fibrovascular proliferation that can cause temporal macular dragging. 1
The age at presentation of FEVR ranges from infancy to adulthood, depending on disease severity; therefore, it should be considered even in adult patients with peripheral neovascularization. 1

Behçet’s disease may manifest with retinal vasculitis that triggers neovascularization and secondary tractional changes. 5
Key clinical clues include recurrent oral/genital ulcers, uveitis, systemic inflammatory symptoms, and evidence of vessel‑wall inflammation on angiography. 5

Eales disease, an idiopathic retinal periphlebitis seen predominantly in young males, can produce peripheral retinal neovascularization. 2

Optical coherence tomography (OCT) should be employed to assess macular thickness, detect epiretinal membranes, and identify tractional alterations caused by fibrovascular tissue. 4
Fasting glucose, HbA1c, and blood pressure measurements are essential to screen for diabetes mellitus and systemic vascular risk factors that may underlie proliferative diabetic retinopathy. 1

In patients older than 50 years presenting with retinal vascular occlusion, giant cell arteritis must be ruled out promptly; immediate high‑dose corticosteroid therapy is required to prevent vision loss in the fellow eye. 5
Distinguishing intraretinal microvascular abnormalities (IRMA) from true neovascularization is critical: IRMA remain confined within retinal layers, whereas neovascular complexes extend into the vitreous cavity. 4
Do not assume that all peripheral neovascularization is diabetic in origin; verify diabetes status and consider alternative diagnoses such as FEVR, Behçet’s disease, or Eales disease, especially in younger patients or those lacking systemic risk factors.

All facts are supported by the cited references and presented in accordance with current ophthalmic practice guidelines.